Nancy K Sweitzer
University of Arizona · UW-Madison · University of Wisconsin, Madison
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Nancy K Sweitzer as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:37 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03252093 · Evaluation of the Safety and Efficacy of Ang-(1-7) to Enhance Cognitive Function in Participants Undergoing CABGUniversity of Arizona · terminated · Coronary Artery Bypass Surgery, Cognitive Impairment · principal investigator
- Ph2NCT03159988 · Angiotensin (1-7) Treatment to Improve Cognitive Functioning in Heart Failure PatientsUniversity of Arizona · suspended · Chronic Heart Failure, Cognitive Impairment · principal investigator
- N/ANCT01354613 · Reduced Contractile Reserve: a Therapeutic Target in Heart Failure With Preserved Ejection Fraction(HFpEF)University of Wisconsin, Madison · completed · Heart Failure With Preserved Ejection Fraction, Pulmonary Disease, Left Ventricular Hypertrophy/Hypertension · principal investigator
- N/ANCT00585611 · Effects of Statin Therapy on Vascular Properties and Outcomes in Diastolic Heart Failure PatientsUniversity of Wisconsin, Madison · terminated · Diastolic Heart Failure · principal investigator
- N/ANCT00585806 · Assessment of Cardiac Functional Reserve in Heart Failure With Preserved Ejection Fraction (HF-PEF)University of Wisconsin, Madison · completed · Heart Failure · principal investigator
- N/ANCT00204945 · Catheterization Laboratory Study: Acute Responses in Diastolic Heart FailureUniversity of Wisconsin, Madison · completed · Heart Failure, Congestive · principal investigator
- N/ANCT00204984 · Heart and Blood Pressure Study: The Effect of Aortic Impedance on Myocardial RelaxationUniversity of Wisconsin, Madison · completed · High Blood Pressure · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Evaluation of the Safety and Efficacy of Angiotensin 1-7 to Enhance Cognitive Function in Participants Undergoing Coronary Artery Bypass Graft (CABG) SurgeryU01HL131014 · NHLBI · UNIVERSITY OF ARIZONA · fiscal years 2017 to 2018 · $622,890 awarded in 2018Grant number is on one of their registry trials
- Reduced contractile reserve: a therapeutic target in heart failure with normal EFR21HL106103 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2011 to 2012 · $185,625 awarded in 2012Grant number is on one of their registry trials
- EFFECT OF AORTIC IMPEDANCE ON MYOCARDIAL RELAXATIONM01RR003186 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2006 to 2007 · $1,687 awarded in 2007Same name and institution; not confirmed by an ID
- MECHANISMS OF DIASTOLIC HEART FAILURE IN AGINGK23AG001022 · NIA · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2000 to 2005 · $108,810 awarded in 2005Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:37 UTC. The ranking covers the 200 most relevant of 28 PubMed records, and a shared surname and initials can bring in a namesake. All 28 on PubMed
- Spironolactone for heart failure with preserved ejection fraction.N Engl J Med · 20142,251 citationsRCR 74.8
- Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.Circulation · 2015882 citationsRCR 29.5
- Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction.Eur Heart J · 2016430 citationsRCR 14.5
- Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone.Circulation · 2015386 citationsRCR 13.9
- Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy.Circulation · 2002326 citationsRCR 7.0
- Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.Circ Heart Fail · 2016284 citationsRCR 11.5
- 250 citationsRCR 7.8
- 240 citationsRCR 7.6
- Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial.Circ Heart Fail · 2013168 citationsRCR 5.2
- Sex Differences in Outcomes and Responses to Spironolactone in Heart Failure With Preserved Ejection Fraction: A Secondary Analysis of TOPCAT Trial.JACC Heart Fail · 2019160 citationsRCR 6.9